Cited by 32Cancer-related Molecular PathwaysGenomics and Chromatin DynamicsDevelopmental Biology and Gene Regulation

The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2

Open access
Willmer, Tarryn, Peres, Jade, Mowla, Shaheen, Abrahams, Amaal, Prince, Sharon·2015·Cell Cycle

Abstract

The transcription factor, TBX3, is critical for the formation of, among other structures, the heart, limbs and mammary glands and haploinsufficiency of the human TBX3 gene result in ulnar-mammary syndrome which is characterized by hypoplasia of these structures. On the other hand, the overexpression of TBX3 is a feature of a wide range of cancers and it has been implicated in several aspects of the oncogenic process. This includes its ability to function as an immortalizing gene and to promote proliferation through actively repressing negative cell cycle regulators. Together this suggests that TBX3 levels may need to be tightly regulated during the cell cycle. Here we demonstrate that this is indeed the case and that TBX3 mRNA and protein levels peak at S-phase and that the TBX3 protein is predominantly localized to the nucleus of S-phase cells. The increased levels of TBX3 in S-phase are shown to occur transcriptionally through activation by c-Myc at E-box motifs located at -1210 and -701 bps and post-translationally by cyclin A-CDK2 phosphorylation. Importantly, when TBX3 is depleted by shRNA the cells accumulate in S-phase. These results suggest that TBX3 is required for cells to transit through S-phase and that this function may be linked to its role as a pro-proliferative factor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15384101.2015.1080398

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A few kinases participate in phosphorylation of TBX3, such as AKT3 at S720, cyclin A-CDK2 at either S190 or S354, p38 MAP kinase at S692, and AKT1 is also involved.

    “Moreover, a few kinases participate in phosphorylation of TBX3, such as AKT3 at S720, cyclin A-CDK2 at either S190 or S354, p38 MAP kinase at S692, and AKT1 is also involved54,59–61.”

    From Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis (2024) · cites this paper as [54]

    The “Cyclin A-CDK2 binds and phosphorylates TBX3” section reports that CDK2 phosphorylates TBX3 within its N-terminal half, but does not identify S190 or S354 as the site. The cited paper’s text does not establish the other kinase–site claims in the sentence; its reference list names a separate AKT3 study, without giving the S720 site. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 47

  1. Papaioannou V, Silver LM. The T-box gene family. Bioessays 1998; 20(1):9-19; PMID:9504043; http:// dx.doi.org/10.1002/(SICI)1521-1878(199801)20:1% 3c9::AID-BIES4%3e3.0.CO;2-Q. · DOI
  2. Smith J. T-box genes: What they do and how they do it. Trends Genet 1999; 15(4):154-8; PMID:10203826; http://dx.doi.org/10.1016/S0168- 9525(99)01693-5 · DOI
  3. Naiche LA, Harrelson Z, Kelly RG, Papaioannou VE. T-box genes in vertebrate development. Ann Rev Genet 2005; 39:219-39; PMID:16285859; http://dx.doi.org/ 10.1146/annurev.genet.39.073003.105925. · DOI
  4. Packham EA, Brook JD. T-box genes in human disorders. Hum Mol Genet 2003; 12:R37-44; PMID:12668595; http://dx.doi.org/10.1093/hmg/ddg077. · DOI
  5. Wansleben S, Peres J, Hare S, Goding CR, Prince S. T- box transcription factors in cancer biology. BBA-Rev on Cancer 2014; 1846(2):380-91.
  6. Lingbeek ME, Jacobs JJL, van Lohuizen M. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J Biol Chem 2002; 277:26120-7; PMID:12000749; http://dx.doi.org/10.1074/jbc. M200403200 · DOI · Paper page
  7. Hoogaars WM, Barnett P, Rodriguez M, Clout DE, Moorman AF, Goding CR, Christoffels VM. TBX3 and its splice variant TBX3 C exon 2a are functionally similar. Pigment Cell Melanoma Res 2008; 21(3):379- 87; PMID:18444963; http://dx.doi.org/10.1111/ j.1755-148X.2008.00461.x · DOI
  8. Burgucu D, Guney K, Sahinturk D, Ozbudak IH, Ozel D, Ozbilim G, Yavuzer U. Tbx3 represses PTEN and is over-expressed in head and neck squa- mous cell carcinoma. BMC Cancer 2012; 12:481; PMID:23082988; http://dx.doi.org/10.1186/1471- 2407-12-481. · DOI · Paper page
  9. Dan J, Li M, Yang J, Li J, Okuka M, Ye X, Liua L. Roles for Tbx3 in regulation of two-cell state and telo- mere elongation in mouse ES cells. Sci Rep 2013; 3:3492; PMID:24336466.
  10. Morgan DO. Principles of CDK regulation. Nature 1995; 374:131-4; PMID:7877684; http://dx.doi.org/ 10.1038/374131a0. · DOI
  11. Lim S, Kaldis P. Cdks, cyclins, and CKIs: roles beyond cell cycle regulation. Development 2013; 140:3079-93; PMID:23861057; http://dx.doi.org/10.1242/dev. 091744. · DOI
  12. Sherr CJ. The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Cell Biol 1994; 4(1):15-8; PMID:14731824; http://dx.doi.org/ 10.1016/0962-8924(94)90033-7. · DOI
  13. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 1995; 15:2612-24; PMID:7739542.
  14. Heichman KA, Roberts JM. Rules to replicate by. Cell 1994; 79:557-62; PMID:7954822; http://dx.doi.org/ 10.1016/0092-8674(94)90541-X. · DOI
  15. King RW, Jackson PK, Kirschner MW. Mitosis in tran- sition. Cell 1994; 79:563-71; PMID:7954823; http:// dx.doi.org/10.1016/0092-8674(94)90542-8. · DOI
  16. Arellano M, Moreno S. Regulation of CDK/cyclin complexes during the cell cycle. Int J Biochem Cell Biol 1997; 29:559-73; PMID:9363633; http://dx.doi. org/10.1016/S1357-2725(96)00178-1. · DOI
  17. Wade M, Wahl GM. c-myc, genome instability, and tumorigenesis: the devil is in the details. Curr Top Micro- biol Immunol 2006; 302:169-203; PMID:16620029.
  18. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 1997; 387:422-6; PMID:9163430; http://dx.doi.org/10.1038/387422a0. · DOI
  19. Rudolph B, Saffrich R, Zwicker J, Henglein B, Muller R, Ansorge W, Eilers M. Activation of cyclin-depen- dent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J 1996; 15:3065-76; PMID:8670807.
  20. Evan G, Wyllie A, Gilbert C, Littlewood T, Land H, Brooks M, Waters C, Penn L, Hancock D. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 63:119-25; http://dx.doi.org/10.1016/0092-8674(92) 90123-T. · DOI
  21. Perez-Roger I, Solomon DLC, Sewing A, Land H. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Onco- gene 1997; 14:2373-81; PMID:9188852; http://dx. doi.org/10.1038/sj.onc.1201197. · DOI
  22. Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B. Growth arrest by the cyclin-dependent kinase inhibi- tor p27Kip1 is abrogated by c-Myc. EMBO J 1996; 15:6595-604; PMID:8978686.
  23. Wu S, Cetinkaya C, Munoz-Alonso M.J, von der Lehr N, Bahram N, Beuger V, Eilers M, Leon J, Larsson L. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 2003; 22:351-60; PMID:12545156; http:// dx.doi.org/10.1038/sj.onc.1206145. · DOI
  24. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Naj- mabadi F, Tyner AL. Myc represses the p21(WAF1/ CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 2001; 98(8):4510-5; PMID:11274368; http://dx.doi.org/10.1073/pnas.081074898. · DOI
  25. Pusch O, Soucek T, Hengstschl€ ager-Ottnad E, Berna- schek G, Hengstschl€ ager M. Cellular targets for activa- tion by c-Myc include the DNA metabolism enzyme thymidine kinase. DNA Cell Biol 1997; 16(6):737-47; PMID:9212167.
  26. Hanson KD, Shichiri M, Follansbee MR, Sedivy JM. Effects of c-Myc expression on cell cycle progression. Mol Cell Biol 1994; 14(9):5748-55; PMID:8065309; http://dx.doi.org/10.1128/MCB.14.9.5748. · DOI
  27. Platonova N, Scotti M, Babich P, Bertoli G, Mento E, Meneghini V, Egeo A, Zucchi I, Merlo GR. TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53. Cell Tissue Res 2007; 328:301-16; PMID:17265068; http://dx.doi.org/ 10.1007/s00441-006-0364-4. · DOI
  28. Govoni KE, Linares GR, Chen ST, Pourteymoor S, Mohan S. T-box 3 negatively regulates osteoblast dif- ferentiation by inhibiting expression of osterix and runx2. J Cell Biochem 2009 Feb 15; 106(3):482-90; http://dx.doi.org/10.1002/jcb.22035. · DOI
  29. Bilican B, Goding CR. Cell cycle regulation of the T- box transcription factor tbx2. Exp Cell Res 2006; 312:2358-66; PMID:16730707; http://dx.doi.org/ 10.1016/j.yexcr.2006.03.033. · DOI
  30. Wansleben S, Davis E, Peres J, Prince S. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance. Cell Death Dis 2013 Oct 10; 4: e846; http://dx.doi.org/10.1038/cddis.2013.365. · DOI
  31. Selmi A, de Saint-Jean M, Jallas AC, Garin E, Hogarty MD, B enard J, Puisieux A, Marabelle A, Valsesia-Witt- mann S. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma. Cancer Lett 2015 Feb 1; 357(1):412-8; http://dx.doi.org/10.1016/j. canlet.2014.11.056. · DOI
  32. Guo J, Li T, Schipper J, Nilson KA, Fordjour FK, Cooper JJ, Gordân R, Price DH. Sequence specificity incom- pletely defines the genome-wide occupancy of Myc. Genome Biol 2014; 15(10):482; PMID:25287278; http://dx.doi.org/10.1186/s13059-014-0482-3. · DOI
  33. Thomas LR, Wang Q, Grieb BC, Phan J, Foshage AM, Sun Q, Olejniczak ET, Clark T, Dey S, Lorey S, et al. Interaction with WDR5 Promotes Target Gene Recog- nition and Tumorigenesis by MYC. Mol Cell 2015 May 7; 58(3):4 40-52.
  34. Barton MC, Crowe AJ. Chromatin alteration, tran- scription and replication: What's the opening line to the story? Oncogene 2001 May 28; 20(24):3094-9; http://dx.doi.org/10.1038/sj.onc.1204334. · DOI
  35. Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 1997; 387:422-6; PMID:9163430; http://dx.doi.org/10.1038/387422a0. · DOI
  36. Pusch O, Soucek T, Hengstschl€ ager-Ottnad E, Berna- schek G, Hengstschl€ ager M. Cellular targets for activa- tion by c-Myc include the DNA metabolism enzyme thymidine kinase. DNA Cell Biol 1997; 16(6):737-47; PMID:9212167.
  37. Valovka T, Sch€ onfeld M, Raffeiner P, Breuker K, Dun- zendorfer-Matt T, Hartl M, Bister K. Transcriptional control of DNA replication licensing by Myc. Sci Rep 2013 Dec 6; 3:3444.
  38. Alevizopoulos K, Vlach J, Hennecke S, Amati B. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblas- toma family proteins. EMBO J 1997 Sep 1; 16(17):5322-33; http://dx.doi.org/10.1093/emboj/ 16.17.5322. · DOI
  39. Ogryzko VV, Wong P, Howard BH. WAF1 retards S- phase progression primarily by inhibition of cyclin- dependent kinases. Mol Cell Biol 1997 Aug; 17 (8):4877-82.
  40. Abrahams A, Mowla S, Parker MI, Goding CR, Prince S.UV-mediated regulation of the anti-senescence factor Tbx2. J Biol Chem 2008 Jan 25; 283(4):2223-30; http://dx.doi.org/10.1074/jbc.M705651200. · DOI · Paper page
  41. Oakes V, Wang W, Harrington B, Lee WJ, Beamish H, Chia KM, Pinder A, Goto H, Inagaki M, Pavey S, Gabrielli B. Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle. Cell Cycle 2014; 13(20):3302-11; PMID:25485510; http://dx. doi.org/10.4161/15384101.2014.949111. · DOI
  42. Akiyama T, Ohuchi T, Sumida S, Matsumotot K, Toyoshima K. Phosphorylation of the retinoblastoma protein by cdk2. Proc Natl Acad Sci USA 1992; 89:7900-4; PMID:1518810; http://dx.doi.org/ 10.1073/pnas.89.17.7900. · DOI
  43. Jaumot M, Estañol JM, Casanovas O, Graña X, Agell N, Bachs O. The cell cycle inhibitor p21CIP is phos- phorylated by cyclin A-CDK2 complexes. Biochem Biophys Res Commun 1997 Dec 18; 241(2):434-8; http://dx.doi.org/10.1006/bbrc.1997.7787. · DOI
  44. Dai L, Liu Y, Liu J, Wen X, Xu Z, Wang Z, Sun H, Tang S, Maguire AR, Quan J, Zhang H, Ye T. A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) deg- radation, cell cycle progression and cell survival: impli- cations in cancer therapy. Cancer Lett 2013 Jun 1; 333 (1):103-12; http://dx.doi.org/10.1016/j.canlet.2013. 01.025. · DOI
  45. Mowla S, Pinnock R, Leaner VD, Goding CR, Prince S. PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration. Biochem J 2011 Jan 1; 433(1):145-53; http://dx.doi. org/10.1042/BJ20100886. · DOI · Paper page
  46. Davis E, Teng H, Bilican B, Parker MI, Liu B, Carriera S, Goding CR, Prince S. Ectopic Tbx2 expression results in polyploidy and cisplatin resistance. Oncogene 2008 Feb 7; 27(7):976-84; http://dx.doi.org/10.1038/ sj.onc.1210701. · DOI
  47. Prince S, Carreira S, Vance KW, Abrahams A, Goding CR. Tbx2 directly represses the expression of the p21 (WAF1) cyclin-dependent kinase inhibitor. Cancer Res 2004 Mar 1; 64(5):1669-74; http://dx.doi.org/ 10.1158/0008-5472.CAN-03-3286. · DOI

Cited by

Sorted by citations

Authors
Willmer, T., Peres, J., Mowla, S., Abrahams, A., & Prince, S.
Affiliations
University of Cape Town (ZA)
Corresponding author
Prince, Sharon
Venue
Cell Cycle
Published
2015-10-02
Volume
14
Issue
19
Pages
3173-3183
ISSN
  • 1538-4101 (ISSN-L)
  • 1551-4005
OpenAlex
W1854747786
Cited by
32
References
3
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 2
FWCI
1.31
Type
journal article
Language
en
Open access
Locations
  • Cell Cycle (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Research Foundation
  • Cancer Association of South Africa
  • University of Cape Town
  • Hasso Plattner Foundation
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
TBX3, S phase, c-Myc, CDK2/cyclin A, transcriptional regulation, E-box motifs, cell cycle regulation, cell proliferation, ulnar-mammary syndrome, haploinsufficiency, oncogenes, nuclear localization, shRNA knockdown
MeSH terms
Animals, Cell Cycle, Cell Line, Chlorocebus aethiops, Flow Cytometry, Fluorescent Antibody Technique, Humans, Blotting, Western, S Phase, COS Cells, Cyclin A, T-Box Domain Proteins, Cell Line, Tumor, Chromatin Immunoprecipitation, Cyclin-Dependent Kinase 2, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review